Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group.
Saved in:
| Title: | Tumoral TP53 and/or CDKN2A alterations are not reliable prognostic biomarkers in patients with localized Ewing sarcoma: a report from the Children's Oncology Group. |
|---|---|
| Authors: | Lerman DM; Department of Orthopedics, University of Utah, Salt Lake City, Utah; Center for Children's Cancer Research, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Monument MJ, McIlvaine E, Liu XQ, Huang D, Monovich L, Beeler N, Gorlick RG, Marina NM, Womer RB, Bridge JA, Krailo MD, Randall RL, Lessnick SL |
| Corporate Authors: | Children's Oncology Group Ewing Sarcoma Biology Committee |
| Source: | Pediatric blood & cancer [Pediatr Blood Cancer] 2015 May; Vol. 62 (5), pp. 759-65. Date of Electronic Publication: 2014 Dec 02. |
| Publication Type: | Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1545-5017 |
|---|---|
| DOI: | 10.1002/pbc.25340 |
